Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resista
| Image |  |
|---|---|
| Description | scientific article published on 18 March 2015 |
| Author/s |
author: Ebrahim Variava Klaus Reither Alexander S Pym Prudence Ive |
| Publication date | March 18, 2015 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |